Avantor Results Presentation Deck
Q4 and FY 2022 highlights
Li
Ongoing business momentum
Strong underlying end market fundamentals despite transitory headwinds
Results in line with updated guidance
2022 core organic growth and margin expansion at/above long-term targets
Executing on our growth strategy
Achieved significant renewal and expansion milestones with top 10 customers
Expanded product portfolio with new proprietary launches, digital innovation
and collaboration agreements
-
Completed manufacturing and distribution expansions in Ireland, Singapore
and U.S.
Looking ahead
Focused on continuous improvement and driving growth; long-term financial
algorithm intact
2023 guidance reflects strong life sciences demand and favorable pricing, offset
by COVID-19 roll-off, destocking, and macroeconomic pressures
Accelerating science-based climate commitments
Navantor™
3View entire presentation